Fact checked byKristen Dowd

Read more

May 04, 2024
1 min read
Save

Nuance Medical acquires Biocorneum silicone gel scar treatment brand

Fact checked byKristen Dowd
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Nuance Medical has acquired Biocorneum, a silicone gel scar treatment brand.
  • The acquisition will go into effect immediately.

Nuance Medical has acquired Biocorneum, a silicone gel scar treatment brand, the company announced in a press release.

Previously owned by Sientra, the scar treatment will be added to Nuance’s portfolio, Biodermis, which specializes in silicone scar management products. According to the release, this acquisition will go into effect immediately.

Generic Industry News infographic
Nuance Medical has acquired Biocorneum, a silicone gel scar treatment brand.

“Bringing Biocorneum into the Biodermis family marks a significant step in our journey to lead with innovative and impactful treatments in scar management,” Mark Steele, president of Nuance Medical, said in the release. “This acquisition integrates Biocorneum’s strong presence in the professional health care sector with Biodermis’ comprehensive range of silicone scar management products. We are excited about the combined capabilities this brings and the enhanced benefits it offers to our health care partners and their patients.”

According to the release, Biodermis has been recognized as a leader of medical-grade silicone treatments for more than 30 years.